Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Immunity|February 15, 2023
A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccineWai Kwan Tang, Camila H Coelho, Kazutoyo Miura, et al.
Plos One|December 28, 2017
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicityPuthupparampil V Scaria, Beth Chen, Christopher G Rowe, et al.
Vaccine|July 15, 2026
Impact of antigen and carrier substitution on the molecular weight and immunogenicity of the Pfs230D1-CRM197 malaria transmission-blocking vaccinePuthupparampil V Scaria, Beth Chen, Olga Muratova, et al.
The American Journal of Tropical Medicine and Hygiene|July 19, 2017
Malaria Infection and Gametocyte Carriage Rates in Preparation for Transmission Blocking Vaccine Trials in Bancoumana, MaliMahamadoun Hamady Assadou, Issaka Sagara, Sara A Healy, et al.
The Journal of Infectious Diseases|July 9, 2018
Antibodies to PfsEGXP, an Early Gametocyte-Enriched Phosphoprotein, Predict Decreased Plasmodium falciparum Gametocyte Density in HumansChristian P Nixon, Christina E Nixon, Ian C Michelow, et al.
NPJ Vaccines|February 22, 2023
Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccineThayne H Dickey, Richi Gupta, Holly McAleese, et al.
Frontiers in Immunology|June 12, 2024
Immunization with PfGBP130 generates antibodies that inhibit RBC invasion by P. falciparum parasitesYannick Johnson, Ahmad Rushdi Shakri, Sunthorn Pond-Tor, et al.
NPJ Vaccines|August 10, 2024
Antibody gene features associated with binding and functional activity in malaria vaccine-derived human mAbsCamila H Coelho, Susanna Marquez, Bergeline C Nguemwo Tentokam, et al.
Vaccine|July 1, 2020
Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230Puthupparampil V Scaria, Beth B Chen, Christopher G Rowe, et al.
The Journal of Infectious Diseases|November 6, 2012
HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stagesCharlotte V Hobbs, Tatiana Voza, Patricia De La Vega, et al.
Pageof 24